Leading stocks in medical consumption sector
Are you also looking for information about leading stocks in medical consumption sector? That's right. Xiaobian carefully arranged this article about leading stocks in medical consumption sector, which should answer your doubts. For more information about leading stocks in medical consumption sector, you can search in the upper right corner.
leading stocks in the medical consumption sector
The leading stocks in the medical consumption sector are:
1. Harbin Sanlian: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include chemical raw materials, chemical preparations, Chinese patent medicines and Chinese herbal pieces.
2. Harbin Pharmaceutical Co., Ltd.: The company is a pharmaceutical enterprise with a history of more than 5 years. Its products include oral liquid, syrup, tablets, capsules, granules and pills.
3. Tibet pharmaceutical industry: The company's main business is drug research and development, production and sales. The main products are antibiotics, cardiovascular, anti-tumor, digestive system, respiratory system, nervous system, anti-virus and so on.
4. Saisheng Pharmaceutical Co., Ltd.: The company is a high-growth pharmaceutical enterprise with generic drugs as the mainstay and innovative drugs as the supplement.
5. Southwest Synthesis: The company's main business is the research and development, production and sales of chemical raw materials and preparation products.
6. Changjiang Health: The company's main business is research and development, production and sales of pharmaceutical products. The main products include chemical synthetic medicine and plant extract medicine.
7. Baike Bio: The company's main business is vaccine research and development, production and sales. The main products include human vaccines and animal vaccines.
8. Rheinland Bio: The company is engaged in the research, development, production and sales of natural plant extracts.
9. Tibet Pharmaceutical Industry: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include antibiotics, cardiovascular, anti-tumor, digestive system, respiratory system, nervous system and anti-virus.
1. Guizhou Bailing: The company is a large-scale pharmaceutical listed company integrating research and development, production and sales of Miao medicine.
11. Zixin Pharmaceutical Co., Ltd. is an enterprise engaged in research and development, production and sales of traditional Chinese medicine.
12. Qianjin Pharmaceutical Co., Ltd. is an enterprise mainly engaged in the production and sales of pediatric drugs, gynecological drugs, antibiotics and other drugs.
13. Jiangzhong Pharmaceutical: The company is a large-scale pharmaceutical listed company integrating drug research and development, production and sales.
14. Lingrui Pharmaceutical: The company is an enterprise engaged in research and development, production and sales of drugs.
15. Jianmin Group: The company's main business is drug research and development, production and sales. The main products include medicines and medical devices.
16. Xinlitai: The company is an enterprise engaged in research and development, production and sales of pharmaceutical products. The main products include cardiovascular, anti-infective and metabolic drugs.
17. China Resources Sanjiu: The company is a leading enterprise in the field of high-end medicine and health in China, mainly engaged in prescription drugs, health products and medical and health services.
18. Kunyao Group: The company is an enterprise engaged in the research and development and production of active components and key intermediates of natural medicines.
19. Jiangzhong Pharmaceutical: The company is a large-scale pharmaceutical listed company integrating drug research and development, production and sales.
2. New Cape: The company is a well-known provider of information solutions for smart hospitals in China, focusing on providing core software and hardware products and solutions for medical digitalization.
21, Bond: The company's main business is research and development, production and sales of Chinese patent medicines and chemical medicines for cardiovascular and cerebrovascular diseases.
22. Tonghua Jinma: The company's main business is the research and development, production and sales of chemical raw materials and preparation products.
23. Shuangcheng Pharmaceutical Co., Ltd. is an enterprise specializing in the research, development, production and sales of chemical synthetic peptides drugs.
24. Harbin Sanlian: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal pieces and so on.
leading stocks in the medical consumption industry
The leading stocks in the medical consumption industry are:
__ Harbin Sanlian (2815): The company signed the Exclusive Promotion Agreement with Arbor Pharmaceutical Group, LLC (hereinafter referred to as Arbor Pharmaceutical) of the United States.
__ Harbin Pharmaceutical Co., Ltd. (6664): The company signed an agreement with Pfizer to obtain the exclusive and non-exclusive promotion right of Zostavax.
__ China Resources Shuanghe (662): The company signed an agreement with Pfizer to obtain the exclusive and non-exclusive promotion right of Xgeva drugs.
__ Jiuzhoutong (6558): medical equipment faucet.
__ New Cape (3248): The new Cape serves hospitals, laboratories and other key business scenarios with independent and controllable intelligent data collection and control products and solutions. Based on a deep understanding of the core business processes of hospitals, it is business-oriented and data-centered, and provides hospitals with all-round digital services such as clinical path optimization, smart logistics, smart materials, smart medical records and medical safety through digital platforms.
The above are only the leading stocks in some medical consumer industries. If you need to know more information, I suggest you pay attention to the company's dynamics and be cautious when investing and financing.
which stocks should I buy after the decline of medical consumer stocks
After the decline of medical consumer stocks, I can consider buying the stocks of other companies in the medical consumer sector, such as:
__ Baiyun Mountain: The company's core products include amoxicillin capsules, ceftriaxone sodium for injection, bismuth pectin, omeprazole enteric-coated tablets, tetrandrine tablets, atorvastatin calcium tablets, simvastatin tablets and so on. Baiyun Mountain Banlangen Granule is one of the leading products of the company, and it has been the champion of Banlangen drug sales for ten consecutive years.
__ Mindray Medical: The company's core products include in vitro diagnostic products, medical imaging equipment, clinical laboratory analysis systems, ultrasonic instruments and equipment, animal medical equipment, rehabilitation products, medical system software, etc.
__ Jianfan Bio: The company's core products include hemoperfusion related products, biomaterials and biological products.
The possible risks of the above stocks include the company's performance fluctuation, policy risk, etc., so the investment should be cautious.
leading stocks of medical consumer stocks
leading stocks of medical consumer stocks are:
_ _ _ _ _ Wan Tai Bio _ _ _ (63392).
_ _ _ _ _ Changchun High-tech _ _ _ (661).
_ _ _ _ _ zhifei creature _ _ _ (3122).
_ _ _ _ _ Opcon _ _ _ (3555).
_ _ _ _ _ Tiger Medicine _ _ _ (3347).
_ _ _ _ _ Huada Gene _ _ _ (3176).
_ _ _ _ _ Mindray Medical _ _ _ (376).
_ _ _ _ _ Yifeng Pharmacy _ _ _ (3937).
_ _ _ _ _ New Industry _ _ _ (3839).
_ _ _ _ _ Lepu Medical _ _ _ (33).
_ _ _ _ _ Lanwei Medicine _ _ _ (63889).
_ _ _ _ _ Wei Xinkang _ _ _ (63657).
_ _ _ _ _ Bishuiyuan _ _ _ (976).
_ _ _ _ _ Huaping shares _ _ _ (374).
_ _ _ _ _ Innovative medical care _ _ _ (2173).
The above are some leading medical consumer stocks. Please note that investment is risky and you should be cautious.
Will medical consumer stocks continue to rise?
Whether medical consumer stocks will continue to rise in the future is a complex issue, which depends on many factors, such as market trends, company performance and policy environment. Medical consumer stocks generally refer to stocks related to human health, such as pharmaceuticals, medical equipment, medical technology, medical care and so on.
At present, the global medical consumer market is growing continuously, which provides a good market foundation for medical consumer stocks. However, the market is always full of uncertainty. When investors invest in medical consumer stocks, they need to conduct in-depth research and analysis on the company's performance, financial situation, industry prospects and other factors.
generally speaking, the future rise of medical consumer stocks depends on many factors, including but not limited to market demand, industry competition pattern, company operating conditions, etc. Investment decisions need to be made according to individual risk tolerance, investment objectives and market environment. It is recommended that you continue to pay attention to market trends and company reports to obtain more accurate forecasts. Before any investment decision, it is recommended to consult a professional investment consultant.
that's all for the introduction of leading stocks in the medical consumption sector.